TGFB1 and diabetic cardiomyopathy: The images in panels D–F underscore the pathological changes in diabetic cardiomyopathy, including hypertrophy and increased TGF-β1 immunoexpression, indicative of fibrotic processes and structural abnormalities (Figure 1).